BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1296567)

  • 1. [Cytogenetics of neuroblastoma and glioma].
    Chudinovskaia NV
    Arkh Patol; 1992; 54(12):33-7. PubMed ID: 1296567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells.
    Barker PE; Savelyeva L; Schwab M
    Oncogene; 1993 Dec; 8(12):3353-8. PubMed ID: 8247537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangement of the human ABL oncogene in a glioblastoma.
    Heisterkamp N; Morris C; Sender L; Knoppel E; Uribe L; Cui MY; Groffen J
    Cancer Res; 1990 Jun; 50(11):3429-34. PubMed ID: 2334939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analyses of the candidate tumor suppressor gene, PLAGL1, in benign and malignant salivary gland tumors.
    Enlund F; Persson F; Stenman G
    Eur J Oral Sci; 2004 Dec; 112(6):545-7. PubMed ID: 15560839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes and anti-oncogenes in human central nervous system tumors.
    Batra SK; Rasheed BK; Bigner SH; Bigner DD
    Lab Invest; 1994 Nov; 71(5):621-37. PubMed ID: 7967518
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and glial tumors.
    Watkins D; Rouleau GA
    Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
    Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P
    Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations.
    Caron H; van Sluis P; van Roy N; Beks L; Maes P; Pereira do Tanque R; Slater R; de Kraker J; Speleman F; Voûte PA
    Prog Clin Biol Res; 1994; 385():35-42. PubMed ID: 7972230
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
    Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
    Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.
    Chernova OB; Somerville RP; Cowell JK
    Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
    Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
    Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning tumor-related genes and tumor suppressor genes in glioma with polymerase chain reaction-based subtractive hybridization].
    Deng YC; Wang JC; Liu XP; Ji SP; Yao LB
    Ai Zheng; 2005 Jun; 24(6):680-4. PubMed ID: 15946478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
    Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
    Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome rearrangement, oncogene activation, and other clonal events in cancer: their use in molecular diagnostics.
    Wiedemann LM; McCarthy KP; Chan LC
    J Pathol; 1991 Jan; 163(1):7-12. PubMed ID: 2002425
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
    Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
    Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of oncogenes and anti-oncogenes].
    Thomas G
    Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetics of human cancer.
    Ankathil R; Vijayakumar T; Nair MK
    Natl Med J India; 1992; 5(2):63-8. PubMed ID: 1304266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.